---
figid: PMC9019181__cdr-4-96.fig.3
figtitle: 'Oxidative stress and redox signaling in CRPC progression: therapeutic potential
  of clinically-tested Nrf2-activators'
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Danio rerio
- Homo sapiens
pmcid: PMC9019181
filename: cdr-4-96.fig.3.jpg
figlink: /pmc/articles/PMC9019181/figure/fig3/
number: F3
caption: 'Multiple signaling cascades are activated following IL-6 binding to its
  receptor (GP130). Ligand binding causes GP130 dimerization and activation (phosphorylation)
  of the associated JAK kinase, which then activates downstream STAT transcription
  factor. GP130 activation can also transduce second messenger signaling via the RAS/RAF/MEK/ERK
  pathway to activate MAP kinase (MAPK). In addition, this inflammatory cytokine can
  also initiate the PI3K signaling at the membrane, which can either activate IκB
  kinase (IKK) and thus enhance NF-κB transcription factor function or PI3K may activate
  the downstream protein kinase B (AKT) which suppress NF-κB activation. Therefore,
  IL-6 signaling activates multiple redox signaling networks that may crosstalk with
  AR and activate it in a ligand-independent manner. IL-6: interleukin-6; JAK: Janus
  associated kinase; STAT: signal transducers and activators of transcription; NF-κB:
  nuclear factor kappa B'
papertitle: 'Oxidative stress and redox signaling in CRPC progression: therapeutic
  potential of clinically-tested Nrf2-activators.'
reftext: Debasis Mondal, et al. Cancer Drug Resist. 2021;4(1):96-124.
year: '2021'
doi: 10.20517/cdr.2020.71
journal_title: Cancer Drug Resistance
journal_nlm_ta: Cancer Drug Resist
publisher_name: OAE Publishing Inc.
keywords: Prostate cancer | androgen receptor | hormone therapy | endocrine resistance
  | oxidative stress | redox signaling | Nrf2 | Nrf2-activators
automl_pathway: 0.9422896
figid_alias: PMC9019181__F3
figtype: Figure
redirect_from: /figures/PMC9019181__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9019181__cdr-4-96.fig.3.html
  '@type': Dataset
  description: 'Multiple signaling cascades are activated following IL-6 binding to
    its receptor (GP130). Ligand binding causes GP130 dimerization and activation
    (phosphorylation) of the associated JAK kinase, which then activates downstream
    STAT transcription factor. GP130 activation can also transduce second messenger
    signaling via the RAS/RAF/MEK/ERK pathway to activate MAP kinase (MAPK). In addition,
    this inflammatory cytokine can also initiate the PI3K signaling at the membrane,
    which can either activate IκB kinase (IKK) and thus enhance NF-κB transcription
    factor function or PI3K may activate the downstream protein kinase B (AKT) which
    suppress NF-κB activation. Therefore, IL-6 signaling activates multiple redox
    signaling networks that may crosstalk with AR and activate it in a ligand-independent
    manner. IL-6: interleukin-6; JAK: Janus associated kinase; STAT: signal transducers
    and activators of transcription; NF-κB: nuclear factor kappa B'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - hop
  - bsk
  - Stat92E
  - ras
  - Ras64B
  - Ras85D
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - par-1
  - Raf
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Dif
  - dl
  - Rel
  - IKKepsilon
  - key
  - IKKbeta
  - il6st
  - il6r
  - stat1b
  - stat4
  - il6
  - stat3
  - rab1ab
  - IL6ST
  - NM
  - LRPPRC
  - IL6R
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - IL6
  - KRAS
  - HRAS
  - NRAS
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - MARK1
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
---
